The Global Non-Invasive Glucose Monitoring Devices Market is witnessing rapid growth, reaching US$29.53 Million in 2023 and projected to rise to US$ 60.71 Million by 2033 at a CAGR of 7.5%. This surge is driven by the increasing prevalence of diabetes worldwide and the growing demand for painless, convenient glucose monitoring solutions. Rising awareness about early disease detection, technological advancements in wearable and sensor-based devices, and the shift toward home healthcare are further boosting adoption. Additionally, the preference for continuous monitoring and minimal hospital visits is fueling market demand, making non-invasive glucose devices a critical tool for diabetes management.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/non-invasive-glucose-monitoring-devices-market?ram

Key Developments:

United States: Non-invasive Glucose Monitoring Developments

✅ October 2025: Senseonics received FDA approval for its Eversense 365 implantable continuous glucose monitoring (CGM) system, offering a sensor lifespan of up to one year.

✅ September 2025: Dexcom launched its Stelo over-the-counter CGM system, designed for adults not on insulin therapy, expanding access to continuous glucose monitoring.

✅ August 2025: Abbott introduced its Lingo CGM system in the U.S., targeting both diabetic and non-diabetic individuals seeking non-invasive continuous glucose monitoring.

✅ July 2025: The FDA cleared Dexcom's G7 15 Day CGM system, allowing for extended wear up to 15.5 days, enhancing convenience for users.

Japan: Non-invasive Glucose Monitoring Developments

✅ October 2025: Japanese researchers announced advancements in non-invasive glucose monitoring technologies, focusing on improving accuracy and user comfort.

✅ September 2025: A Japanese medical technology company unveiled a prototype non-invasive glucose monitoring device utilizing optical sensor technology, aiming for commercialization.

✅ August 2025: The Japanese government initiated a pilot program to evaluate the effectiveness of non-invasive glucose monitoring devices in clinical settings.

✅ July 2025: Collaborations between Japanese universities and healthcare companies led to the development of a wearable non-invasive glucose monitoring system, currently undergoing clinical trials.

Recent Mergers and Acquisitions:

United States: Non-invasive Glucose Monitoring M&A

✅ October 2025: Dexcom acquired a startup specializing in AI algorithms for glucose trend prediction, enhancing the predictive capabilities of its CGM systems.

✅ September 2025: Abbott Laboratories completed the acquisition of a company focused on non-invasive glucose monitoring technologies, expanding its diabetes care portfolio.

Japan: Non-invasive Glucose Monitoring M&A

✅ October 2025: A Japanese medical device manufacturer merged with a biotechnology firm to jointly develop non-invasive glucose monitoring solutions.

✅ August 2025: A Japanese healthcare company entered into a partnership with an international firm to co-develop wearable non-invasive glucose monitoring devices, aiming for global market expansion.

Key Players:

=> Know Labs, Inc., Conga Medical Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Medtronic, Abbott Laboratories, Dexcom, Inc., Afon Technology, Ascensia Diabetes Care, and BlueSemi

Growth Forecast Projected:

The Global Non-invasive Glucose Monitoring Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the Global Non-invasive Glucose Monitoring Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=non-invasive-glucose-monitoring-devices-market?ram

Key Segments:

➥ By Product Type: Wearable Devices, Non-wearable Devices

➥ By Technology: Optical, Transdermal, Enzymatic, Electromagnetic, Thermal, Ultrasound

➥ By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes

➥ By End User: Hospitals & Clinics, Home Care Settings, Diagnostic Centers, Research Institutes

Regional Analysis for Non-invasive Glucose Monitoring Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.